- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6544
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy ; volume:10 ; number:2 ; day:29 ; month:9 ; year:2021 ; pages:445-464 ; date:12.2021
Cardiology and therapy ; 10, Heft 2 (29.9.2021), 445-464, 12.2021
- Creator
-
Tsioufis, Konstantinos
Castellano Vázquez, José María
Sykara, Georgia
Mondello Malvestiti, Franco
Vugt, Joris van
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40119-021-00240-8
- URN
-
urn:nbn:de:101:1-2022010807034814204155
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsioufis, Konstantinos
- Castellano Vázquez, José María
- Sykara, Georgia
- Mondello Malvestiti, Franco
- Vugt, Joris van
- SpringerLink (Online service)
Other Objects (12)
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany
Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases